Cargando…

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

In the first part, the following mechanisms involved in different forms of cell death are considered, with a view to identifying potential therapeutic targets: tumour necrosis factor receptors (TNFRs) and their engagement by tumour necrosis factor-alpha (TNF-α); poly [ADP-ribose] polymerase (PARP)-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, G., Walker, A. J., Berk, M., Maes, M., Puri, B. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994217/
https://www.ncbi.nlm.nih.gov/pubmed/29052145
http://dx.doi.org/10.1007/s12035-017-0793-y
_version_ 1783330395229519872
author Morris, G.
Walker, A. J.
Berk, M.
Maes, M.
Puri, B. K.
author_facet Morris, G.
Walker, A. J.
Berk, M.
Maes, M.
Puri, B. K.
author_sort Morris, G.
collection PubMed
description In the first part, the following mechanisms involved in different forms of cell death are considered, with a view to identifying potential therapeutic targets: tumour necrosis factor receptors (TNFRs) and their engagement by tumour necrosis factor-alpha (TNF-α); poly [ADP-ribose] polymerase (PARP)-1 cleavage; the apoptosis signalling kinase (ASK)-c-Jun N-terminal kinase (JNK) axis; lysosomal permeability; activation of programmed necrotic cell death; oxidative stress, caspase-3 inhibition and parthanatos; activation of inflammasomes by reactive oxygen species and the development of pyroptosis; oxidative stress, calcium dyshomeostasis and iron in the development of lysosomal-mediated necrosis and lysosomal membrane permeability; and oxidative stress, lipid peroxidation, iron dyshomeostasis and ferroptosis. In the second part, there is a consideration of the role of lethal and sub-lethal activation of these pathways in the pathogenesis and pathophysiology of neurodegenerative and neuroprogressive disorders, with particular reference to the TNF-α-TNFR signalling axis; dysregulation of ASK-1-JNK signalling; prolonged or chronic PARP-1 activation; the role of pyroptosis and chronic inflammasome activation; and the roles of lysosomal permeabilisation, necroptosis and ferroptosis. Finally, it is suggested that, in addition to targeting oxidative stress and inflammatory processes generally, neuropsychiatric disorders may respond to therapeutic targeting of TNF-α, PARP-1, the Nod-like receptor NLRP3 inflammasome and the necrosomal molecular switch receptor-interacting protein kinase-3, since their widespread activation can drive and/or exacerbate peripheral inflammation and neuroinflammation even in the absence of cell death. To this end, the use is proposed of a combination of the tetracycline derivative minocycline and N-acetylcysteine as adjunctive treatment for a range of neuropsychiatric disorders.
format Online
Article
Text
id pubmed-5994217
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-59942172018-06-22 Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists Morris, G. Walker, A. J. Berk, M. Maes, M. Puri, B. K. Mol Neurobiol Article In the first part, the following mechanisms involved in different forms of cell death are considered, with a view to identifying potential therapeutic targets: tumour necrosis factor receptors (TNFRs) and their engagement by tumour necrosis factor-alpha (TNF-α); poly [ADP-ribose] polymerase (PARP)-1 cleavage; the apoptosis signalling kinase (ASK)-c-Jun N-terminal kinase (JNK) axis; lysosomal permeability; activation of programmed necrotic cell death; oxidative stress, caspase-3 inhibition and parthanatos; activation of inflammasomes by reactive oxygen species and the development of pyroptosis; oxidative stress, calcium dyshomeostasis and iron in the development of lysosomal-mediated necrosis and lysosomal membrane permeability; and oxidative stress, lipid peroxidation, iron dyshomeostasis and ferroptosis. In the second part, there is a consideration of the role of lethal and sub-lethal activation of these pathways in the pathogenesis and pathophysiology of neurodegenerative and neuroprogressive disorders, with particular reference to the TNF-α-TNFR signalling axis; dysregulation of ASK-1-JNK signalling; prolonged or chronic PARP-1 activation; the role of pyroptosis and chronic inflammasome activation; and the roles of lysosomal permeabilisation, necroptosis and ferroptosis. Finally, it is suggested that, in addition to targeting oxidative stress and inflammatory processes generally, neuropsychiatric disorders may respond to therapeutic targeting of TNF-α, PARP-1, the Nod-like receptor NLRP3 inflammasome and the necrosomal molecular switch receptor-interacting protein kinase-3, since their widespread activation can drive and/or exacerbate peripheral inflammation and neuroinflammation even in the absence of cell death. To this end, the use is proposed of a combination of the tetracycline derivative minocycline and N-acetylcysteine as adjunctive treatment for a range of neuropsychiatric disorders. Springer US 2017-10-19 2018 /pmc/articles/PMC5994217/ /pubmed/29052145 http://dx.doi.org/10.1007/s12035-017-0793-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Morris, G.
Walker, A. J.
Berk, M.
Maes, M.
Puri, B. K.
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title_full Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title_fullStr Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title_full_unstemmed Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title_short Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
title_sort cell death pathways: a novel therapeutic approach for neuroscientists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994217/
https://www.ncbi.nlm.nih.gov/pubmed/29052145
http://dx.doi.org/10.1007/s12035-017-0793-y
work_keys_str_mv AT morrisg celldeathpathwaysanoveltherapeuticapproachforneuroscientists
AT walkeraj celldeathpathwaysanoveltherapeuticapproachforneuroscientists
AT berkm celldeathpathwaysanoveltherapeuticapproachforneuroscientists
AT maesm celldeathpathwaysanoveltherapeuticapproachforneuroscientists
AT puribk celldeathpathwaysanoveltherapeuticapproachforneuroscientists